While your data companions rushed off to jobs in finance and government, you remained adamant that science was the way for you. Staying true to your mission, you've joined Pymaceuticals Inc., a burgeoning pharmaceutical company based out of San Diego. Pymaceuticals specializes in anti-cancer pharmaceuticals. In its most recent efforts, it began screening for potential treatments for squamous cell carcinoma (SCC), a commonly occurring form of skin cancer.
Apart of a team as a data analyst , I've been given access to the complete data from their most recent animal study. In this study, 249 mice identified with SCC tumor growth were treated through a variety of drug regimens. Over the course of 45 days, tumor development was observed and measured. The purpose of this study was to compare the performance of Pymaceuticals' drug of interest, Capomulin, versus the other treatment regimens. I have been tasked by the executive team to generate all of the tables and figures needed for the technical report of the study. The team also has asked for a top-level summary of the study results.